G
Gereon R. Fink
Researcher at Forschungszentrum Jülich
Publications - 976
Citations - 67974
Gereon R. Fink is an academic researcher from Forschungszentrum Jülich. The author has contributed to research in topics: Medicine & Functional magnetic resonance imaging. The author has an hindex of 114, co-authored 867 publications receiving 60853 citations. Previous affiliations of Gereon R. Fink include University of Geneva & University of Hamburg.
Papers
More filters
Journal ArticleDOI
Volumetry of [¹¹C]-methionine positron emission tomographic uptake as a prognostic marker before treatment of patients with malignant glioma.
Norbert Galldiks,Veronika Dunkl,Lutz W. Kracht,Stefan Vollmar,Andreas H. Jacobs,Gereon R. Fink,Michael Schroeter +6 more
TL;DR: The data suggest that pretreatment volumetry of MET uptake but not the semiquantitative MET uptake ratio is a useful biologic prognostic marker in patients with malignant glioma.
Journal ArticleDOI
Neural interaction between spatial domain and spatial reference frame in parietal-occipital junction
TL;DR: The results suggest that the parietal–occipital junction (POJ) not only shows a preference for near-space processing but is also involved in the neural interaction between spatial domains and spatial reference frames.
Journal ArticleDOI
Early treatment response evaluation using FET PET compared to MRI in glioblastoma patients at first progression treated with bevacizumab plus lomustine
Norbert Galldiks,Norbert Galldiks,Veronika Dunkl,Garry Ceccon,C. Tscherpel,Gabriele Stoffels,Ian Law,Otto M. Henriksen,Aida Muhic,Hans Skovgaard Poulsen,Jan Steger,E K Bauer,Philipp Lohmann,Matthias Schmidt,Nadim Joni Shah,Gereon R. Fink,Karl-Josef Langen +16 more
TL;DR: FET-PET appears to be useful for identifying responders to BEV/LOM early after treatment initiation, and its predictive ability was evaluated subsequently concerning OS using uni- and multivariate survival estimates.
Journal ArticleDOI
Quality of life outcome after subthalamic stimulation in Parkinson's disease depends on age
Haidar S. Dafsari,Paul Reker,Lisa Stalinski,Monty Silverdale,Alexandra Rizos,Keyoumars Ashkan,Michael T. Barbe,Gereon R. Fink,Julian Evans,Julia K. Steffen,Michael Samuel,Till A. Dembek,Veerle Visser-Vandewalle,Angelo Antonini,K. Ray-Chaudhuri,Pablo Martinez-Martin,Lars Timmermann +16 more
TL;DR: How quality of life outcome after bilateral subthalamic nucleus (STN) deep brain stimulation in Parkinson's disease (PD) depends on age is investigated.
Journal ArticleDOI
Neuronavigation for transcranial magnetic stimulation (TMS): where we are and where we are going.
TL;DR: The key problems of neuronavigation for TMS are delineated and how they can be addressed by modern neuronavigational strategies.